Category Archives: Cancer Research

CTCA Offers Wide-range of Jobs to Qualified and Service-oriented Healthcare Professionals

Cancer Treatment Centers of America, popularly known as CTCA, is a hospital network in the United States that focuses on cancer care. It has more than 30 years of expertise in designing personalized treatment and care for its patients. Interestingly, the network offers a wide range of jobs to healthcare and non-healthcare professionals. It communicated its need for service-oriented professionals who are ready to go an extra mile to ensure the personalized care a unique experience. The network needs a large number of registered nurses to its network with an excellent pay structure. Currently, the hospital group hires Infusion registered nurses to its Scottsdale clinic.

The full-time opportunity demands a minimum of two years expertise in an oncology environment. People who wanted to join the network should hold the Arizona Registered Nurse certification. Patient care technician is another major vacancy reported in the network. The part-time opportunity requires high school graduation and current BLS to join the network. Additionally, an experience of at least six months as a Nurse Aide especially from a clinic or hospital environment. People who completed the training program for Nurse Aid can also apply for the vacancy. Currently, the hospital network is hiring for its Newnan and Tulsa locations, and the job is offering an excellent salary above the national average.

Clinical Scheduling coordinator is another major vacancy the network wants more people into its network. The full-time vacancies are similar to clerical roles and offer fixed schedule and hours of work. People who have completed high school diploma are eligible to apply for the job. Additionally, CTCA prefers people with three years of experience in medical scheduling and holders of Business Associates degree. Infection Control Practitioner is another major vacancy reported by the cancer treatment network. The full-time opportunity is for Philadelphia location and Certification in Infection Control, or CIC is a must to apply for the job. The job also needs a clinical background experience including medical technologist, registered nurse, and more.

While coming to the education, the applicants should be bachelors in microbiology, epidemiology, or any other subject related to healthcare or life science with a minimum experience of five years in infection control area. Another major opportunity reported with the network is a switchboard operator. The full-time opportunity is for Goodyear, AZ, and the applicants should have completed GED or high school diploma. People from the customer service background are preferred for the job. Business Services Manager is another major opportunity that is full-time as well as having fixed day hours. The job also needs GED or high school diploma and at least four years of exposure in a healthcare office or related offices. The applicants should have experience in registration, collection, and insurance. The opportunity is for Goodyear, AZ, location.

Under Clay Siegall’s Stewardship, Seattle Genetics Expands Its Product line

Seattle Genetics is a Bothell-based Cancer Drug Company that has been making significant investments in its product line. It has also embarked on hiring many employees. The company is succeeding in expanding the use of Adcetris, its first drug. The expansion program includes the development of 12 new drugs and recruiting over 100 employees. Some will work in the U.S. and others in its Switzerland office. Seattle Genetics is testing Adcetris against different types of lymphomas. The company will conduct a more advanced phase of clinical trial. The only commercialized drug, Adcetris, will be used as the main drug in treatment of new diagnosis of Hodgkin Lymphoma and its previous untreated cases.
Clay Siegall, CEO of Seattle Genetics, said that the results of the trials would mark a major milestone in the program. Adcetris is widely used to treat Lymphoma patients. The drug earned the company huge revenues of $226 million from sales in Canada and U.S. in 2015. There is a high possibility that the sales proceeds will increase this year. Seattle Genetics partnered with Takeda Pharmaceutical to sell the drug outside Canada and the U.S. Among the 12 drugs that are being manufactured, one drug is for treating acute myeloid leukemia- 33A, two drugs for bladder cancer and one drug for breast cancer. These drugs will be tested in subsequent clinical trials. This information was originally mentioned on bizjournals.com.

About Clay Siegall
Clay Siegall is the principal, CEO, and Chairman of the Board of Directors of Seattle Genetics, a company that he co-founded in 1998. Clay has provided Seattle Genetics’s employees with a favorable environment to develop a wide range of cancer treatments. They include ADCETRIS, a drug that was approved in 2011 by the U.S. Food and Drug Administration (FDA). Under his leadership, Seattle Genetics has secured over $675 million from both public and private funding. Before co-founding Seattle Genetics, Siegall worked for other companies like the National Cancer Research and Bristol-Myers Squibb Pharmaceutical Research Institute. He plays an active role as a member of the Board of Directors for Alder BioPharmaceuticals and Mirna Therapeutics. Clay is a successful author with more than 70 publications. He is a graduate of the renowned George Washington University where he earned a PhD in Genetics. He is also an alumnus of the esteemed University of Maryland where he pursued a B.S. in Zoology. This information was originally published on CrunchBase.